Lyndal K. Hesterberg
2018
In 2018, Lyndal K. Hesterberg earned a total compensation of $850.6K as Chief Scientific Officer at Oncocyte Corp, a 184% increase compared to previous year.
Compensation breakdown
| Bonus | $311,820 |
|---|---|
| Option Awards | $314,940 |
| Salary | $216,691 |
| Other | $7,132 |
| Total | $850,583 |
Hesterberg received $314.9K in option awards, accounting for 37% of the total pay in 2018.
Hesterberg also received $311.8K in bonus, $216.7K in salary and $7.1K in other compensation.
Rankings
In 2018, Lyndal K. Hesterberg's compensation ranked 9,932nd out of 14,244 executives tracked by ExecPay. In other words, Hesterberg earned more than 30.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,932 out of 14,244 | 30th |
Division Manufacturing | 4,009 out of 5,759 | 30th |
Major group Chemicals And Allied Products | 1,505 out of 2,122 | 29th |
Industry group Drugs | 1,270 out of 1,811 | 30th |
Industry In Vitro and In Vivo Diagnostic Substances | 43 out of 72 | 40th |
Source: SEC filing on June 18, 2019.
Hesterberg's colleagues
We found two more compensation records of executives who worked with Lyndal K. Hesterberg at Oncocyte Corp in 2018.